The new review looked at five randomized trials and found mixed outcomes. Small studies can point toward possibilities or reveal where more careful work is needed. Notably, the most promising signals came from trials with women diagnosed with major depressive disorder, a detail that raises questions about biology, hormones, or how trials are designed and who gets studied.
For anyone interested in human potential and more inclusive treatments, this line of research matters because it explores an affordable, widely available compound that could widen therapeutic options. The current evidence isn’t decisive, but the pattern invites deeper trials that consider sex differences, dosing, and which patients might benefit most. Follow the link to see how these findings might reshape thinking about energy, mood, and equitable access to new treatment strategies.
Creatine is best known as a muscle-building supplement, but scientists are now investigating whether it could also help treat depression by boosting the brain’s energy supply. A new review examined five randomized clinical trials involving 238 participants and found mixed results. Two studies, both involving women with major depressive disorder, reported that adding creatine to standard treatment improved symptoms, while three others found no meaningful benefit.
